Evaluation of preservative effectiveness of p-coumaric acid derivatives in aluminium hydroxide gel-USP

2013 ◽  
Vol 4 (2) ◽  
pp. 144 ◽  
Author(s):  
Arun Nanda ◽  
Balasubramanian Narasimhan ◽  
Anurag Khatkar
Keyword(s):  
Aluminium Hydroxide ◽  
Coumaric Acid ◽  
Aluminium Hydroxide Gel

Purification of Activated Bovine Hageman Factor

1963 ◽  
Vol 09 (03) ◽  
pp. 546-556 ◽  
Author(s):  
John G. G Schoenmakers ◽  
R. M Kurstjens ◽  
C Haanen ◽  
F. Zilliken
Keyword(s):  
Human Plasma ◽  
Aluminium Hydroxide ◽  
Clotting Factors ◽  
Hageman Factor ◽  
Assay Procedure ◽  
Bovine Plasma ◽  
Aluminium Hydroxide Gel

SummaryActivated Hageman Factor has been purified 3000 to 5000 fold from citrated bovine plasma as measured in a thoroughly devised assay procedure. The steps of purification include adsorption on aluminium hydroxide gel, glass, diethyl- aminoethyl cellulose and Sephadex G-200. A fractionation according to Cohn between step 2 and 3 renders the factor more stable for further purification. The purified preparations corrected the clotting defect in human plasma with Hageman trait. The most purified fractions were devoid of plasma thromboplastin antecedent (PTA), other clotting factors.

The Effect of Aluminium Hydroxide Orally on Calcium, Phosphorus and Aluminium Metabolism in Normal Subjects

1976 ◽  
Vol 51 (4) ◽  
pp. 407-414 ◽  
Author(s):  
J. M. Cam ◽  
V. A. Luck ◽  
J. B. Eastwood ◽  
H. E. de Wardener
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Aluminium Hydroxide ◽  
Normal Subjects ◽  
The Other ◽  
Calcium Balance ◽  
Phosphorus Balance ◽  
Calcium Phosphorus ◽  
Aluminium Hydroxide Gel ◽  
Plasma Phosphorus

1. Five normal subjects were given 100 ml of aluminium hydroxide gel per day for 28 days. 2. The phosphorus balance became more positive in one subject, less negative in two and changed from negative to positive in the other two subjects. This was accompanied by a rise in the concentration of the fasting morning plasma phosphorus. Calcium balance did not change. 3. The normal subjects absorbed 0·3–3·6 mmol of aluminium/day, which is significantly less than that absorbed by five patients with chronic renal failure, three of whom were studied before, and two after, the observations on the normal subjects had been completed. 4. In a further five normal subjects on 100 ml of aluminium hydroxide gel/day the 08.00 hours concentration of plasma phosphorus did not fall, though there was a fall at 11.00, 14.00 and 17.00 hours.

Butazolidin alka mantle tablets

1969 ◽  
Vol 7 (3) ◽  
pp. 12.1-12
Keyword(s):  
Aluminium Hydroxide ◽  
Magnesium Trisilicate ◽  
Gastric Sensitivity ◽  
Aluminium Hydroxide Gel

Butazolidin alka tablets (Geigy) contain 100 mg phenylbutazone ensheathed in a compression-coated ‘mantle’ of dried aluminium hydroxide gel BP 100 mg and magnesium trisilicate BP 150 mg. They are promoted for use in patients who have manifested ‘gastric sensitivity’ while taking uncoated phenylbutazone or other anti-rheumatic drugs.

Sign in / Sign up

Export Citation Format

Share Document